NCT04497363View on ClinicalTrials.gov

Focused Ultrasound for the Treatment of ADHD Symptoms

NAEnrolling by invitationINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

October 30, 2025

Study Completion Date

March 2, 2026

Conditions
ADHD
Interventions
DEVICE

Brainsonix Pulsar 1002

Each participant will undergo 8 consecutive weekly sessions (each session is 10 minutes long) of focused ultrasound with the Brainsonix Pulsar 1002 device.

Trial Locations (2)

90403

Neurological Associates of West LA, Santa Monica

Neurological Associates of West Los Angele, Santa Monica

All Listed Sponsors
lead

Neurological Associates of West Los Angeles

OTHER